"10.1371_journal.pone.0065689","plos one","2013-06-12T00:00:00Z","M Cris Silva-Santisteban; Isaac M Westwood; Kathy Boxall; Nathan Brown; Sam Peacock; Craig McAndrew; Elaine Barrie; Meirion Richards; Amin Mirza; Antony W Oliver; Rosemary Burke; Swen Hoelder; Keith Jones; G Wynne Aherne; Julian Blagg; Ian Collins; Michelle D Garrett; Rob L M van Montfort","Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey, United Kingdom; Division of Structural Biology, The Institute of Cancer Research, Chester Beatty Laboratories, Chelsea, London, United Kingdom","Conceived and designed the experiments: MCSS IMW KB NB CM EB AM MDG IC RLMvM. Performed the experiments: MCSS IMW KB NB SP CM EB MR AM. Analyzed the data: MCSS IMW KB SP MR AWO RB SH KJ GWA JB IC MDG RLMvM. Contributed reagents/materials/analysis tools: AWO IC SH KJ JB RB GWA RLMvM. Wrote the paper: MCSS IMW RLMvM.","The authors are current or former employees of The Institute of Cancer Research, which has a commercial interest in the development of checkpoint kinase inhibitors. The authors confirm that there are no patents relating to materials pertinent to this article. The authors commercial interest in the development of checkpoint kinase inhibitors does not alter their adherence to all the PLOS ONE policies on sharing data and materials.","2013","06","M Cris Silva-Santisteban","MCSS",18,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
